Angel Lazarov
Director, Head of Clinical Data Management @Marengo Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Director, Head of Clinical Data Management @Marengo Therapeutics
EDUCATION
Harvard Online
Data Science: R Basics
Harvard Online
Contract Law: From Trust to Promise to Contract
HMX – Harvard Medical School
HMX Pro Immunology - Immuno-oncology
BTECH
Environmental Chemistry
MIT Professional Education
Entrepreneurial Negotiations
HMX – Harvard Medical School
The FDA and Prescription Drugs: Drug Development and Approval
HMX – Harvard Medical School
HMX Pro Genetics-Cancer Genomics and Precision Oncology
Columbia University
Statistical Thinking for Data Science and Analytics
SKILLS
ABOUT ANGEL LAZAROV
I’m a dynamic and growth-focused Certified Clinical Data Manager with extensive experience in steering cross-functional teams, optimizing clinical data strategies, and accelerating clinical trial delivery through innovative data integration and centralized monitoring practices.Being a forward-thinking Clinical Data Management leader, I have successfully built and scaled high-performing teams from n of 1, deployed transformative technologies like Spotfire and aligned data management with regulatory and corporate goals. I am known for fostering strategic vendor partnerships, pioneering data-driven decision-making frameworks, and championing operational excellence across rare disease and oncology portfolios.As a compassionate and motivational team builder and mentor, I consistently empower teams to achieve clinical development milestones while upholding the highest regulatory and compliance standards. I strive to provide value as a company resource and have consistently achieved recognition, awards, and promotional opportunities through my leadership in clinical data governance, technology deployment, and strategic clinical trial execution.A few of my career highlights include:• Steered the creation and implementation of the company’s EDC-to-safety systems data integration and safety processes, accelerating process scalability and response during the COVID-19 pandemic.• Directed the redesign of safety data CRFs that enhanced operational efficiency at investigative sites for submitting initial and follow-up safety cases via EDC.• Established and led a Local Labs Subject Matter Team to manage reference ranges, unit conversions, and CRO oversight, effectively eliminating local lab data as a bottleneck for data analysis readiness and database locks.\"The greatest danger in times of turbulence is not the turbulence—it is to act with yesterday’s logic.\" – Peter Drucker
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.